NL-OMON24018尚未招募不适用
Effects of GLP1 agonist liRAglutiDE in patients with antispychotic-drUgs-associATEd diabetes mellitus
MC Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Informed consent obtained before any trial related activities
- •Males or females aged 18 years or older
排除标准
- •Any type of diabetes present before the use of anti-psychotic drugs
- •Use of glucose-lowering medication other than metformin
研究者
相似试验
进行中（未招募）
不适用
Assessing the efficacy and safety of the GLP1-agonist liraglutide in patients who developed diabetes as a consequence of the use of anti-psychotic drugsEUCTR2013-005395-18-NLniversity Medical Center Utrecht
撤回
4 期
Effects of GLP1 agonist liraglutide in patients with antipsychotic-drugs-associated diabetes mellitus10018424Diabetes MellitusNL-OMON40321Interne geneeskunde50
进行中（未招募）
1 期
EFFECTS OF THE GLP-1 RECEPTOR AGONIST LIRAGLUTIDE ON LOWER LIMB PERFUSION IN PEOPLE WITH TYPE 2 DIABETES AND PERIPHERAL ARTERY DISEASE: A RANDOMIZED CONTROLLED TRIAPeripheral Artery Disease and type 2 diabetes mellitusMedDRA version: 20.0Level: LLTClassification code 10053246Term: Type II diabetes peripheral angiopathySystem Organ Class: 100000004866EUCTR2020-002940-22-ITA.O.U. Università degli Studi della Campania Luigi Vanvitelli50
终止
3 期
Study of Liraglutide in Individuals With Type 2 Diabetes Using InsulinType 2 DiabetesNCT01628445University of Manitoba52
Unknown
不适用
Effect of Liraglutide on Clock GenesType 2 DiabetesNCT02783196Tel Aviv University14